ecromeximab

Uses your system voice; voice and rate in settings.

Q3718768Snapshot

≈ 1 min read

Names in other languages

  • العربيةإكرومكسيماب
  • Englishecromeximab
  • Françaisecromeximab
  • ItalianoEcromeximab
  • NederlandsEcromeximab
  • 中文依美昔单抗

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Ecromeximab is a chimeric monoclonal antibody being developed for the treatment of melanoma. The drug was developed by Kyowa Hakko Kogyo Co., Ltd. As of December 2015 development had been discontinued.

Ecromeximab is a chimeric monoclonal antibody being developed for the treatment of melanoma. The drug was developed by Kyowa Hakko Kogyo Co., Ltd. As of December 2015 development had been discontinued.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1322608541 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.